Both authors contributed equally to this work.
Minireview
Bioelectrochemical Systems: An Outlook for Practical Applications
Article first published online: 5 JUN 2012
DOI: 10.1002/cssc.201100732
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Sleutels, T. H. J. A., Ter Heijne, A., Buisman, C. J. N. and Hamelers, H. V. M. (2012), Bioelectrochemical Systems: An Outlook for Practical Applications. ChemSusChem, 5: 1012–1019. doi: 10.1002/cssc.201100732
- †
Both authors contributed equally to this work.
Publication History
- Issue published online: 5 JUN 2012
- Article first published online: 5 JUN 2012
- Manuscript Revised: 8 MAR 2012
- Manuscript Received: 15 NOV 2011
Funded by
- Dutch Ministry of Economic Affairs
- European Union European Regional Development Fund
- Province of Fryslan
- EZ-KOMPAS Program of the “Samenwerkingsverband Noord-Nederland”
- Abstract
- Article
- References
- Cited By
Keywords:
- costs;
- fuel cells;
- electrolysis cell;
- microbes;
- resistance
Abstract
Bioelectrochemical systems (BESs) hold great promise for sustainable production of energy and chemicals. This review addresses the factors that are essential for practical application of BESs. First, we compare benefits (value of products and cleaning of wastewater) with costs (capital and operational costs). Based on this, we analyze the maximum internal resistance (in mΩ m2) and current density that is required to make microbial fuel cells (MFCs) and hydrogen-producing microbial electrolysis cells (MECs) cost effective. We compare these maximum resistances to reported internal resistances and current densities with special focus on cathodic resistances. Whereas the current densities of MFCs still need to be increased considerably (i.e., internal resistance needs to be decreased), MECs are closer to application as their current densities can be increased by increasing the applied voltage. For MFCs, the production of high-value products in combination with electricity production and wastewater treatment is a promising route.

1864-564X/asset/olbannerleft.gif?v=1&s=fc58be2772ff226734ef9ecf997ece0903885c67)
1864-564X/asset/olbannercenter.gif?v=1&s=da1d79329c83d74f32e7f59c9ec1b60f04484201)
1864-564X/asset/olbannerright.gif?v=1&s=5014c732b7ee11feab4c51d9cb84f12b575c99ce)
